FindTrial
Sign In

Endoscopic Thyroidectomy via Areola Approach for Stage T1 Papillary Thyroid Carcinoma: Feasibility, Safety, and Oncologic Outcomes

Endoscopic Thyroidectomy via Areola Approach for Stage T1 Papillary Thyroid Carcinoma: Feasibility, Safety, and Long-Term Oncologic Outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077109
Enrollment
Unknown
Registered
2023-10-31
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

ETAA group:NA
COT group:NA

Sponsors

The first people's hospital of Zunyi
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with PTC and treated with ETAA or COT in Zunyi First People's Hospital between January 2021 and June 2022

Exclusion criteria

Exclusion criteria: Patients were excluded based on the following criteria: (1) Age less than 18 or over 60 years; (2) Pre-operative ultrasound showed tumour > 2cm; (3) Definite extra-thyroidal expansion with encapsulation invasion and invasion of adjacent organs; (4) Cervical lateral lymph nodes and/or distant metastasis; (5) Previous neck surgery or radiation therapy; (6) Poor general condition and inability to tolerate general anaesthesia; and (7) other histologic type cancers. =

Design outcomes

Primary

MeasureTime frame
operative time ;—

Secondary

MeasureTime frame
Postoperative satisfaction;Postoperative extubation time;Scar self-awareness and quality of life;—

Countries

China

Contacts

Public ContactJinlong Huo

The first people's hospital of Zunyi

527636479@qq.com+86 182 7553 9929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026